Detection of Group A Streptococcus (GAS) in Oral Cavity

Tonsillitis Clinical Trial

Official title:

Detection of Group A Streptococcus (GAS) in Oral Cavity Using Molecular Techniques

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02972437
• Other study ID #: naamap-HMO-CTIL
• Status: Not yet recruiting
• Phase: N/A
• First received: November 16, 2016
• Last updated: November 27, 2016
• Start date: December 2016
• Est. completion date: January 2018

Study information

• Verified date: November 2016
• Source: Hadassah Medical Organization
• Contact: saar hashavya, doctor
• Phone: 972 53 223 3987
• Email: saarha[@]gmail.com
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The investigators intend to screen children who are suspected of having GAS tonsillitis. From each child we will take a throat culture and saliva sample to screen for molecular evidence of GAS.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: January 2018
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 3 Years to 16 Years

Eligibility

Inclusion Criteria:

• clinical evidence of GAS tonsillitis

• healthy, no chronic illness

• not a GAS carrier

Exclusion Criteria:

• GAS carrier

• Active background disease

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Tonsillitis

Intervention

Other:
• sample taking
throat culture and oral cavity sample

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Hadassah Medical Organization

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	molecular detection of GAS compared to throat culture detection	3 days after taking the oral sample, the investigators will compare it to the throat culture taken at the same time.	3 days	No